Day: December 27, 2018

BrainStorm Expands Manufacturing of NurOwn® for Phase 2 Progressive MS Trial

From Startup Brainstorm Cell Therapeutics Link to Full Article: http://ir.brainstorm-cell.com/phoenix.zhtml?c=142287&p=irol-newsArticle&ID=2381587 BrainStorm has contracted with the Connell and O’Reilly Families Cell Manipulation Core Facility at Dana-Farber Cancer Institute, currently supporting the Phase 3 ALS Trial, to Produce NurOwn® NEW YORK and BOSTON, Dec. 26, 2018 (GLOBE NEWSWIRE) — BrainStorm Cell Therapeutics